H. JAMES BRENTZEL, JR.,MARIA LOPEZ-BRESNAHAN,NAZIH AMMOURY
申请号：
US16782094
公开号：
US20200155477A1
申请日:
2020.02.05
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to the use of multiple doses of Cladribine combined with beta interferon for the treatment of multiple sclerosis in patients who are refractory to at least one conventional therapy.
